Compare, Analyse Piramal Healthcare with ACTAVIS INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PIRAMAL ENTERPRISES vs ACTAVIS (US) - Comparison Results

PIRAMAL ENTERPRISES     Change

Piramal Enterprises has a presence in custom manufacturing, critical care OTC and financial services. To give a boost to its custom manufacturing operations, the company had acquired Avecia Pharmaceuticals, UK in 2005 and Pfizer's Morpeth facility in... More

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PIRAMAL ENTERPRISES   ACTAVIS
EQUITY SHARE DATA
    PIRAMAL ENTERPRISES
Mar-19
ACTAVIS
Dec-18
PIRAMAL ENTERPRISES/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs3,30314,276-   
Low Rs1,7979,577-   
Sales per share (Unadj.) Rs716.53,502.0-  
Earnings per share (Unadj.) Rs79.7-1,128.0-  
Cash flow per share (Unadj.) Rs107.9369.0-  
Dividends per share (Unadj.) Rs28.000-  
Dividend yield (eoy) %1.10-  
Book value per share (Unadj.) Rs1,477.514,444.1-  
Shares outstanding (eoy) m184.45332.60-   
Bonus/Rights/Conversions IS--  
Price / Sales ratio x3.63.4 104.5%   
Avg P/E ratio x32.0-10.6 -302.6%  
P/CF ratio (eoy) x23.632.3 73.1%  
Price / Book Value ratio x1.70.8 209.0%  
Dividend payout %35.10-   
Avg Mkt Cap Rs m470,2923,966,766 11.9%   
No. of employees `0007.816.9 46.3%   
Total wages/salary Rs m22,5040-   
Avg. sales/employee Rs Th16,899.468,921.0 24.5%   
Avg. wages/employee Rs Th2,877.70-   
Avg. net profit/employee Rs Th1,879.9-22,199.5 -8.5%   
INCOME DATA
Net Sales Rs m132,1531,164,765 11.3%  
Other income Rs m3,12822,274 14.0%   
Total revenues Rs m135,2811,187,039 11.4%   
Gross profit Rs m66,29030,523 217.2%  
Depreciation Rs m5,202497,912 1.0%   
Interest Rs m44,09767,214 65.6%   
Profit before tax Rs m20,119-512,328 -3.9%   
Minority Interest Rs m3,1940-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0130,664 0.0%   
Tax Rs m8,611-6,493 -132.6%   
Profit after tax Rs m14,701-375,171 -3.9%  
Gross profit margin %50.22.6 1,914.2%  
Effective tax rate %42.81.3 3,377.5%   
Net profit margin %11.1-32.2 -34.5%  
BALANCE SHEET DATA
Current assets Rs m122,742477,726 25.7%   
Current liabilities Rs m310,810422,612 73.5%   
Net working cap to sales %-142.34.7 -3,007.6%  
Current ratio x0.41.1 34.9%  
Inventory Days Days2320 117.8%  
Debtors Days Days3966 58.6%  
Net fixed assets Rs m116,904131,845 88.7%   
Share capital Rs m3690-   
"Free" reserves Rs m272,1610-   
Net worth Rs m272,5304,804,111 5.7%   
Long term debt Rs m270,1961,691,702 16.0%   
Total assets Rs m856,2617,509,919 11.4%  
Interest coverage x1.5-6.6 -22.0%   
Debt to equity ratio x1.00.4 281.5%  
Sales to assets ratio x0.20.2 99.5%   
Return on assets %6.9-4.1 -167.5%  
Return on equity %5.4-7.8 -69.1%  
Return on capital %12.4-4.8 -256.6%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m10,3120-   
CASH FLOW
From Operations Rs m-115,975416,127 -27.9%  
From Investments Rs m-8,265228,607 -3.6%  
From Financial Activity Rs m107,525-714,198 -15.1%  
Net Cashflow Rs m-16,650-69,117 24.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 73.78 Rs / USD

Compare PIRAMAL ENTERPRISES With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare PIRAMAL ENTERPRISES With: NATCO PHARMA  GSK PHARMA  DISHMAN PHARMA  ABBOTT INDIA  DR. REDDYS LAB  



Today's Market

Sensex Ends 110 Points Lower; Smallcap & Midcap Stocks Outperform(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower, ahead of Q2 GDP data.

Related Views On News

PIRAMAL ENTERPRISES Announces Quarterly Results (1QFY21); Net Profit Up 22.1% (Quarterly Result Update)

Aug 25, 2020 | Updated on Aug 25, 2020

For the quarter ended June 2020, PIRAMAL ENTERPRISES has posted a net profit of Rs 5 bn (up 22.1% YoY). Sales on the other hand came in at Rs 29 bn (down 16.2% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES Announces Quarterly Results (3QFY20); Net Profit Up 11.7% (Quarterly Result Update)

Feb 5, 2020 | Updated on Feb 5, 2020

For the quarter ended December 2019, PIRAMAL ENTERPRISES has posted a net profit of Rs 6 bn (up 11.7% YoY). Sales on the other hand came in at Rs 38 bn (up 9.1% YoY). Read on for a complete analysis of PIRAMAL ENTERPRISES's quarterly results.

PIRAMAL ENTERPRISES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 9, 2019 | Updated on Jul 9, 2019

Here's an analysis of the annual report of PIRAMAL ENTERPRISES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of PIRAMAL ENTERPRISES. Also includes updates on the valuation of PIRAMAL ENTERPRISES.

More Views on News

Most Popular

Stocks that Could Shine More than Gold After Diwali (Profit Hunter)

Nov 17, 2020

If the markets become volatile over the next few months, do this.

Not Infosys or Wipro. India's Next Wealth Creators Could Be Drone Stocks (Profit Hunter)

Nov 25, 2020

India's drones directorate signals the next big defence tech multibaggers.

How the New Margins Will Impact You (Fast Profits Daily)

Nov 25, 2020

The new rules on margins will come into effect from 1st December. Are you ready?

How to Build the Best Trading System (Fast Profits Daily)

Nov 20, 2020

In this video, I'll show you how to make the best trading system.

An Eraser and Some Pencils (The Honest Truth)

Nov 17, 2020

Ajit Dayal on the road ahead for the world after covid.

More
-->

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

OUR TOP 5 IDEAS

Free Report: Multibagger Stock Ideas 2021
Are You Making One of These 15 Costly Mistakes While Investing. Learn more!
Covid-19 Proof Multibagger Stocks - Download this FREE Report Now
Free Report: The Secret to Increasing Your Trading Profits Daily!
No Guessing, No Hunches, and No Missed Trends Ever! Join Us on YouTube Now.

PIRAMAL ENTERPRISES SHARE PRICE


Nov 27, 2020 (Close)

TRACK PIRAMAL ENTERPRISES

  • Track your investment in PIRAMAL ENTERPRISES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PIRAMAL ENTERPRISES

PIRAMAL ENTERPRISES 8-QTR ANALYSIS

COMPARE PIRAMAL ENTERPRISES WITH

FEATURED VIDEOS

Adani Green: A Future Multibagger or a Big, Speculative Bubble

Is M&M the ITC of Auto Sector?

Don't Let Brokerages Fool You into Buying HUL & Nestle. The Real Money is in These Stocks Right Now...

What to Expect from Stocks during Covid Second Wave?

More Featured Videos

MARKET STATS